Cited by 137Testicular diseases and treatmentsCannabis and Cannabinoid ResearchGlobal Cancer Incidence and Screening

The DOI matches its Crossref record; 29 of the 35 references it cites were found in a registry or an index.

Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis

Open access

Abstract

BACKGROUND: The aetiology of testicular cancer remains elusive. In this manuscript, we review the evidence regarding the association between cannabis use and testicular cancer development. METHODS: In this systematic review and meta-analysis, we reviewed literature published between 1(st) January 1980 and 13(th) May 2015 and found three case-control studies that investigated the association between cannabis use and development of testicular germ cell tumours (TGCTs). RESULTS/CONCLUSIONS: Using meta-analysis techniques, we observed that a) current, b) chronic, and c) frequent cannabis use is associated with the development of TGCT, when compared to never-use of the drug. The strongest association was found for non-seminoma development--for example, those using cannabis on at least a weekly basis had two and a half times greater odds of developing a non-seminoma TGCT compared those who never used cannabis (OR: 2.59, 95% CI 1.60-4.19). We found inconclusive evidence regarding the relationship between cannabis use and the development of seminoma tumours. It must be noted that these observations were derived from three studies all conducted in the United States; and the majority of data collection occurred during the 1990's.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12885-015-1905-6

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flow chart of systematic review investigating association between cannabis exposure and testicular cancer development
Fig. 1 Flow chart of systematic review investigating association between cannabis exposure and testicular cancer developmentCC BY · PubMed Central
Fig. 2 Forest plots – with odds ratios and heterogeneity statistics – for a ever-use, b current use, c > = weekly use, and d > =10 years of use. (Total = all histological types)
Fig. 2 Forest plots – with odds ratios and heterogeneity statistics – for a ever-use, b current use, c > = weekly use, and d > =10 years of use. (Total = all histological types)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Research works printed but not linked: 5

  1. UNODC. World drug report. New York: United Nations; 2014.
  2. McGlynn KA, Cook MB. The epidemiology of testicular cancer. Male reproductive cancers: epidemiology, pathology and genetics. New York: Springer; 2009.
  3. Lacson JCA, Carroll JD, Tuazon E, Castelao EJ, Bernstein L, Cortessis VK. Population-based case–control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk. Cancer. 2012;118(21):5374–83. doi: 10.1002/cncr.27554 . · DOI
  4. Stroup D, Berlin J, Morton S, Olkin I, Williamson G, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008–12. doi: 10.1001/jama.283.15.2008 . · DOI · Paper page
  5. Kirkwood BR, Sterne JA. Essential medical statistics. 2nd ed. Malden: Blackwell Science Ltd; 2003.

Cited by

Sorted by citations

Items 101–109 of 109

Metadata

Authors
Gurney, J., Shaw, C., Stanley, J., Signal, V., & Sarfati, D.
Affiliations
University of Otago (NZ)
Corresponding author
Gurney, J.
Venue
BMC Cancer
Published
2015-11-11
Volume
15
Issue
1
Pages
897-897
ISSN
1471-2407 (ISSN-L)
OpenAlex
W2118479499
Cited by
137
References
35
Citations by year
2026: 2 · 2025: 10 · 2024: 9 · 2023: 25 · 2022: 16 · 2021: 15 · 2020: 19 · 2019: 18 · 2018: 14 · 2017: 7 · 2016: 2
FWCI
1.47
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Health Research Council of New Zealand (NZ) (14/052)
Topics
  • Health Sciences › Medicine › Surgery › Testicular diseases and treatments
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Keywords
cannabis use, testicular cancer, testicular germ cell tumors, non-seminoma, seminoma, cancer risk factors, chronic cannabis use, case-control study
MeSH terms
Cannabis, Humans, Male, Neoplasms, Germ Cell and Embryonal, Risk Factors, Testicular Neoplasms, United States, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review